Liminatus Pharma, Inc.
LIMN
$0.65
-$0.06-8.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,441.49% | -- | -- | -87.10% | |
| Total Receivables | -- | -- | -- | 288.25% | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 378.90% | -- | -- | 609.09% | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | 66.79% | |
| Total Current Assets | -72.55% | -- | -- | 135.70% | |
|
|
|||||
| Total Current Assets | -72.55% | -- | -- | 135.70% | |
| Net Property, Plant & Equipment | 1,180.00% | -- | -- | 0.00% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 0.24% | -- | -- | -- | |
| Total Assets | -70.24% | -- | -- | 141.26% | |
|
|
|||||
| Total Accounts Payable | -52.29% | -- | -- | 59.06% | |
| Total Accrued Expenses | -93.82% | -- | -99.94% | 260.96% | |
| Short-term Debt | -92.52% | -- | -- | 24.44% | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 264.57% | -- | -- | 0.00% | |
| Total Other Current Liabilities | 264.57% | -- | -- | 0.00% | |
| Total Current Liabilities | -87.87% | -- | -99.99% | 37.22% | |
|
|
|||||
| Total Current Liabilities | -87.87% | -- | -99.99% | 37.22% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -92.52% | -- | -- | 24.44% | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | -87.35% | -- | -99.99% | 37.22% | |
|
|
|||||
| Common Stock & APIC | 211.60% | -- | -100.00% | 0.00% | |
| Retained Earnings | -7.97% | -- | 100.00% | -14.12% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 91.39% | -- | 99.99% | -22.45% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 91.39% | -- | 99.99% | -22.45% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 91.39% | -- | 99.99% | -22.45% | |
|
|
|||||